ELAHEREHCP.COM: Keyword Density Checker

Total words: 1843 | 2-word phrases: 480 | 3-word phrases: 530 | 4-word phrases: 547

PAGE INFO

Title	Try to keep the title under 60 characters (99 characters) ELAHERE® (mirvetuximab soravtansine-gynx) for Injection, a Prescription medicine \| HCP Website
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (119 characters) ELAHERE is the first treatment to show statistically significant improvements vs standard single-agent chemotherapy1-3*

#	Keyword	Frequency	Density
1	elahere support services	4	0.75%
2	platinumresistant ovarian cancer	4	0.75%
3	1833elahere1833elahere for the	3	0.57%
4	for the elahere	3	0.57%
5	all rights reserved	3	0.57%
6	support services program	3	0.57%
7	practices video open	2	0.38%
8	video open eye	2	0.38%
9	open eye care	2	0.38%
10	dropdown menu support	2	0.38%
11	menu support elahere	2	0.38%
12	responsibility for their	2	0.38%
13	support services how	2	0.38%
14	of immunogen inc	2	0.38%
15	services how to	2	0.38%
16	how to order	2	0.38%
17	to order elahere	2	0.38%
18	jcode for elahere	2	0.38%
19	for elahere test	2	0.38%
20	elahere test for	2	0.38%
21	best practices video	2	0.38%
22	care provider video	2	0.38%
23	trademarks of immunogen	2	0.38%
24	provider video patient	2	0.38%
25	downloadable resources open	2	0.38%
26	proactive management eye	2	0.38%
27	care proactive management	2	0.38%
28	eye care proactive	2	0.38%
29	menu eye care	2	0.38%
30	trademarks or registered	2	0.38%

#	Keyword	Frequency	Density
1	1833elahere1833elahere for the elahere	3	0.55%
2	warranties of any kind	2	0.37%
3	calculating aibw instructions for	2	0.37%
4	practices video open eye	2	0.37%
5	best practices video open	2	0.37%
6	trademarks of immunogen inc	2	0.37%
7	care provider video patient	2	0.37%
8	care proactive management eye	2	0.37%
9	eye care proactive management	2	0.37%
10	menu eye care proactive	2	0.37%
11	epithelial ovarian fallopian tube	2	0.37%
12	ovarian fallopian tube or	2	0.37%
13	fallopian tube or primary	2	0.37%
14	administration dose modifications open	2	0.37%
15	inc all rights reserved	2	0.37%
16	premedication calculating aibw instructions	2	0.37%
17	dropdown menu support elahere	2	0.37%
18	no warranties of any	2	0.37%
19	2024 immunogen inc all	2	0.37%
20	open safety dropdown menu	2	0.37%
21	safety open safety dropdown	2	0.37%
22	trial safety open safety	2	0.37%
23	singlearm trial safety open	2	0.37%
24	© 2024 immunogen inc	2	0.37%
25	most common aes laboratory	2	0.37%
26	safety most common aes	2	0.37%
27	menu safety most common	2	0.37%
28	dropdown menu safety most	2	0.37%
29	video open eye care	2	0.37%
30	support services how to	2	0.37%
31	characteristics singlearm trial data	2	0.37%
32	or use in any	2	0.37%
33	of any kind whatsoever	2	0.37%
34	any kind whatsoever regarding	2	0.37%
35	kind whatsoever regarding their	2	0.37%
36	content use or application	2	0.37%
37	use or application and	2	0.37%
38	or application and disclaims	2	0.37%
39	application and disclaims any	2	0.37%
40	and disclaims any responsibility	2	0.37%

#	URL	Whois	Check
1	https://elahere.com/pdf/prescribing-information.pdf	Whois	elahere.com
2	https://www.elahere.com/	Whois	elahere.com
3	https://www.elahere.com/	Whois	elahere.com
4	https://www.elahere.com/	Whois	elahere.com